Oxandrolone 6.25mg Capsule

Oxandrolone 6.25 mg Capsule is a low-dose oral anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). It is FDA-approved for clinical use to promote weight gain in patients experiencing involuntary weight loss due to surgery, chronic infection, trauma, or catabolic illness, and to support recovery in conditions causing protein loss. Oxandrolone has a high anabolic-to-androgenic ratio, meaning it primarily promotes lean body mass and protein synthesis while minimizing androgenic effects such as virilization. It binds to androgen receptors in muscle and other tissues, enhancing nitrogen retention, muscle protein synthesis, and tissue repair. A 6.25 mg capsule represents a lower-dose option, typically used for gradual anabolic support, pediatric applications, or for patients sensitive to higher doses. Clinical monitoring is essential to manage potential side effects, including liver toxicity, alterations in lipid profiles, and suppression of natural hormone production. Clinical evidence demonstrates oxandrolone’s ability to improve lean body mass and recovery in catabolic states: https://www.ncbi.nlm.nih.gov/books/NBK547716/ Pharmacology and safety profile overview: https://pubmed.ncbi.nlm.nih.gov/25953087/